Cargando…
The catalytic activity of TET2 is essential for its myeloid malignancy-suppressive function in hematopoietic stem/progenitor cells
Autores principales: | Zhao, Zhigang, Chen, Shi, Zhu, Xingguo, Pan, Feng, Li, Rong, Zhou, Yuan, Yuan, Weiping, Ni, Hongyu, Yang, Feng-Chun, Xu, Mingjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972674/ https://www.ncbi.nlm.nih.gov/pubmed/27003514 http://dx.doi.org/10.1038/leu.2016.56 |
Ejemplares similares
-
TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2(−/−)-Driven Myeloid Malignancy Progression
por: Li, Rong, et al.
Publicado: (2017) -
Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis
por: Ito, Kyoko, et al.
Publicado: (2019) -
Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells
por: Pan, Feng, et al.
Publicado: (2017) -
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
por: Feng, Yimei, et al.
Publicado: (2019) -
Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency
por: Wang, Jinhuan, et al.
Publicado: (2020)